Breakthrough T1D hosted a walk on Saturday in support of the cure for type 1 diabetes and those living with the disease. The ...

At Retina World Congress 2025, Dilsher S. Dhoot, MD, shares updates on the HELIOS trial and the potential future of tyrosine ...

Those risk factors include age, sex, diabetes ... for kidney-related issues between 2003 and 2017 in the San Luis Valley. In the U.S., more than 1 in 7 adults has chronic kidney disease.

1 Division of Nephrology and Hypertension ... We addressed key regulatory pathways involved in modulating the progression of kidney fibrosis and discussed their potential implications for future ...

Enjoy sweet treats without the sugar spike with these diabetic-friendly sweeteners. Federal judge blocks Trump order that could disenfranchise millions of voters Big Lots reopening 130 stores in May.

TARPON SPRINGS, Fla., April 25, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing ...

On Wednesday, pharmaceutical giant Eli Lilly sued four prominent telehealth companies that offer more affordable, off-brand versions of its patented best-selling GLP-1 medications Mounjaro and ...

and the risk of Alzheimer’s disease and related dementias. The research is supported by funding from the National Institute on Aging and the National Institute of Diabetes and Digestive and Kidney ...

Orforglipron, a once-daily glucagon-like peptide-1 (GLP-1) receptor agonist, significantly reduced hemoglobin A1c (HbA1c) in adults with type 2 diabetes (T2D) and inadequate glycemic control with diet ...

The new disease, distinct from Type 1 and 2 diabetes, was officially recognised through a vote on 8 April at the IDF's World Diabetes Congress in Bangkok, Thailand following years of debate over its ...